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ABSTRACT
Bone marrow edema syndrome is characterized by increased interstitial fluid in the bone marrow and is a rare disease in children and 
adolescents. Therefore, to make this diagnosis, it should be considered in the differential diagnosis of musculoskeletal system pain. With 
this perspective, the aim was to present a 17-year-old patient who was diagnosed on magnetic resonance imaging with bone marrow edema 
and to highlight characteristics of this rare condition in the pediatric and adolescent population.
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INTRODUCTION 
Bone marrow edema syndrome (BMES) is a rare and usually self-
limiting exclusion syndrome characterized by increased interstitial 
fluid in the bone marrow, which may cause severe pain at times. The 
disease is generally observed in the hip joint in the adult patient group. 
It rarely involves some other joints. It is often misdiagnosed, as its 
clinical findings are highly variable and non-specific. To make a correct 
diagnosis, clinicians should be aware of the syndrome and in patients 
presenting with musculoskeletal pain, the differential diagnosis should 
include BMES, especially when patient history and laboratory testing 
indicates low risk of other common causes. The disease usually resolves 
within a year without any sequelae [1-3].
CASE REPORT
A 17-year-old male patient was admitted to the emergency room with 
severe back pain, which had been intermittent for 2 months but had 
increased in the past week. There was no history of trauma. It was 
learned that the patient had undertaken heavy exercise at home, 2 
days before admission. It was observed that his pain decreased with 
rest and massage, but increased after exercise and persisted in the 
following days. There was no pathological feature in the personal and 
family history. On physical examination, it was noted that his pain 
increased with movement around the scapula and could be exacerbated 
or relieved depending on his lying position. This pain was at a level 
that interfered with the daily activity of the patient. No pathology 
was found in the patient’s laboratory tests. In particular, acute-phase 
reactants and sedimentation were normal. In terms of possible muscle-
tendon pathologies, bilateral scapula and shoulder magnetic resonance 
imaging (MRI) were performed. MRI imaging of the left scapula revealed 
BMES (Fig. 1). After diagnosis, nonsteroidal anti-inflammatory therapy 
(NSAID) and bed rest were ordered. His complaints disappeared within 
3 days and the patient was discharged on NSAID. The patient reattended 
1 week later for follow-up, and he remained symptom and problem 
free. We wanted to present this case to contribute to the literature. The 
patient consent taken before presenting this case.
DISCUSSION
BMES has been increasingly seen in the literature in recent years. In 
general, patients present with pain that restricts daily activities [1,4]. 
It is a syndrome that was first identified and defined by MRI in 1988. 
It is mostly seen in middle-aged patients and in joints such as hip 
and knee [5,6]. BMES may develop due to mechanical, reactive, 
or ischemic causes but the pathogenesis is not fully understood. 
Increased intraosseous pressure and progression of cartilage 
damage have been shown as the cause of the pain. Histological 
findings vary according to the underlying etiology. Recovery without 
any sequelae is thought to be related to the self-renewal capacity 
of bone. Differential diagnosis of bone marrow syndrome findings 
due to pathologies such as mechanical, ischemic, malignancy, and 
osteomyelitis is mostly made by physical examination, history, 
laboratory findings, and imaging methods. MRI is especially helpful 
in diagnosis. However, the differential diagnosis should be made 
meticulously not to miss a serious underlying pathology [7-11]. 
Some signal changes are evident on MRI and are characterized by 
low signal intensity in T1-weighted images and high signal intensity 
in T2-weighted imaging [4,10,12,13]. In our case, the diagnosis was 
made because of hyperintense areas on T2 imaging. Although this 
syndrome is rarely seen in children, it was possible to diagnose this 
patient based on MRI findings. Although it is rare in the shoulder 
area, it is probable that it was caused by overuse.
BMES can be divided into three stages. The 1st month is 
characterized by severe pain and dysfunction. After 1–2 months, 
the pain reaches a maximum level. In the following months, the 
pain gradually decreases and heals without any sequelae. While 
pain symptoms increase with the load on the affected area, pain 
decreases with rest. Patients usually try to protect the affected 
area and avoid actions involving excessive weight [14-16]. In our 
patient, the pain had started around 2 months before presentation 
and had worsened recently, probably associated with the episode 
of heavy exercise.
Treatment can vary depending on the underlying causes. Therefore, 
treatment should be arranged according to the etiology. Since BMES 
is a self-limiting syndrome, the main goal of treatment is to reduce 
pain and shorten the duration of symptoms. Patients may be advised 
to rest for 3–6 weeks and NSAIDs are given for symptoms. Oral NSAID 
can provide symptomatic relief without changing the underlying 
pathology [9,17,18].
Case Report
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In a patient presenting with musculoskeletal pain, BMES should be 
considered in the differential diagnosis, especially after more common 
reasons are excluded from the study.
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Fig. 1: Bone marrow edema in the acromion: In the T1 sequence, 
hypointense appearance (arrow on the left); and in T2 sequence, 
hyperintense appearance (arrow on the right
